Ryan Allway July 28th, 2021 Validates Cepharanthine’s potential in treating various cancers with unsatisfactory treatment options Positions Cepharanthine’s ‘pipeline in a pill’ strategy focusing on esophageal, colorectal, liver and skin cancers Advance to FDA IND-enabling studies to support human clinical studies Toronto, Ontario–(Newsfile Corp. – July 28, 2021) –... Read more